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Summary and Implications 
 Teat dipping with effective products is a critical control 
point for mastitis prevention. Objective of this study was to 
determine efficacy of a novel antimicrobial solution 
containing citrate ion, methylene blue, parabens and 
emollients (ZuraLacSD, Zurex PharmAgra) used as a post-
milking teat dip against a positive control and negative 
control in reducing the incidence of new intramammary 
infections during a period of experimental exposure of teats 
to contagious mastitis organisms, Streptococcus agalactiae 
and Staphylococcus aureus. Novel germicide post milking 
teat dip significantly (P < 0.01%) reduced the number of 
new infections of Streptococcus agalactiae and 
Staphylococcus aureus compared to both the negative 
control (95.3%) and positive control (80.9%) treatments. 
Incidence of clinical mastitis with a bacteriological positive 
identification of one of the challenge organisms was 40, 4 
and 0 for negative control, positive control and novel 
germicide dips, respectively.  Under the conditions of this 
study, no differences were visually observed for teat skin 
condition among the treatments. 
 The use of a novel germicide used in a post-milking teat 
dip significantly reduced the number of new intramammary 
infections (new IMI) caused by experimental challenge with 
contagious mastitis pathogens Strep. agalactiae and 
Staphylocccus aureus  compared to no post-milking teat 
dipping (negative control) and to an industry standard, 0.5% 
iodine post-milking teat dip. 
 
Introduction 
 Teat dipping with effective products is a critical control 
point for mastitis prevention. Objective of this study was to 
determine efficacy of a novel antimicrobial solution 
containing citrate ion, methylene blue, parabens and 
emollients (ZuraLacSD, Zurex PharmAgra) used as a post-
milking teat dip against a positive control and negative 
control in reducing the incidence of new intramammary 
infections during a period of experimental exposure of teats 
to contagious mastitis organisms, Streptococcus agalactiae 
and Staphylococcus aureus. 
  
 
 
Materials and Methods 
1. Animal Selection: 120 Holstein cows were used in an 
eight week trial during the fall / winter 2013. 40 cows 
were assigned to each of 3 treatments.  Each treatment 
group consisted of 30% 1st lactation and 70% 2nd and 
3rd lactation animals.  All cows started the study 
within 60 - 122 days in milk and were milked 2X/ 
day.  Infection status of all quarters was determined 7 
days prior to study initiation.  Cows were not assigned 
to the study with Streptococcus agalactiae, 
Staphylococcus aureus and Streptococci uberis 
infected quarters and blemished teats.  
2. Treatments: Three treatments were: experimental dip - 
ZuraLacSD (Zurex PharmAgra, LLC) containing 
10.0% trisodium citrate with 5.0% emollients used as 
a post-milking teat dip; positive control – TheratecR 
(GEA Farm Technologies, Inc.) containing 0.5% 
iodine with a 3% triple emollient system used as a 
post-milking teat dip; and a negative control where no 
post-milking teat dipping occurred. For the teat dip 
treatments, teats were fore-stripped, pre-dipped with 
TheratecR and dried 30 – 45 seconds later with dry 
cloth towels.  For the negative control treatment, teats 
were fore-stripped and cleaned with moist cloth 
towels with subsequent drying with dry cloth towels.  
Milking machines were attached within two minutes 
of forestripping.  All of the teats in each treatment 
were dipped immediately after machine removal at 
the morning milking with the experimental culture 
broth suspension of Streptococcus agalactiae (ATCC 
55194) and Staphylococcus aureus (ATCC 12600).  
For the post-milking teat dipping treatments, the teats 
were manually dipped with the appropriate teat dip 
between two and five minutes after the teats being 
dipped with the culture broth suspension. 
3.  Bacteriological Sampling: Duplicate quarter samples 
were taken aseptically weekly (Monday AM milking) 
to determine the bacteriological status of each quarter.  
A third sample was taken at the Thursday AM 
milking when the results of the first two differed.  
Duplicate quarter milk samples were collected at the 
time of clinical mastitis.  
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4. Criteria for Determining Infections: Criteria for new 
IMI:  Same bacterium was isolated from: 1) two 
consecutive samples during the trial (> 500 cfu/ml); 
2) duplicate samples from a quarter with clinical 
mastitis (> 100 cfu/ml); and 3) three consecutive 
samples during the trial (> 100 cfu/ml).  An individual 
quarter was eligible for only one infection of the 
challenge organism. 
5. Data Analysis: Infection data were analyzed based on 
percent eligible quarters becoming infected with 
respective mastitis pathogens. The following statistic 
was applied: 
   t = [(x1 / n1) – (x2 / n2)] / [(x1 + x2)/(n1n2)]0.5 
 
where t = approximates Student’s t statistic, x1 = number of 
new IMI in control quarters, x2 = number of new IMI in 
treated quarters, n1 = (number of control quarters) (time 
unit) and n2 = (number of treated quarters) (time unit). The 
denominators n1 and n2 were expressed as the summation of 
quarter-days. The percent reduction in new infection rate in 
the treatment group compared with that in the control group 
was expressed as:  100 [(x1/n1) – (x2 / n2)] / (x1 / n1) 
 
 
 
 
 
 
Results and Discussion 
 Efficacy data for novel germicide product used as a 
post-milking teat dip against an experimental challenge of 
Streptococcus agalactiae and Staphylococcus aureus and 
compared against number of new IMI for a negative control 
and a positive control treatment are presented in Table 1. 
 Novel germicide post milking teat dip significantly (P < 
0.01%) reduced the number of new infections of 
Streptococcus agalactiae and Staphylococcus aureus 
compared to both the negative control (95.3%) and positive 
control (80.9%) treatments. Incidence of clinical mastitis 
with a bacteriological positive identification of one of the 
challenge organisms was 40, 4 and 0 for negative control, 
positive control and novel germicide dips, respectively.  
Under the conditions of this study, no differences were 
visually observed for teat skin condition among the 
treatments. 
 
Overall Conclusion 
 The use of a novel germicide used in a post-milking teat 
dip significantly reduced the number of new intramammary 
infections (new IMI) caused by experimental challenge with 
contagious mastitis pathogens Strep. agalactiae and 
Staphylocccus aureus  compared to no post-milking teat 
dipping (negative control) and to an industry standard, 0.5% 
iodine post-milking teat dip.  
 
 
 
 
Table 1. Efficacy data of novel germicide when used as a post-milking teat dip against an experimental challenge of 
Streptococcus agalactiae and Staphylococcus aureus and compared with a negative control and a positive control treatment. 
 New Infections (New IMI) % reduction 
vs. control 
 Clin.** Subclinical** Total** % Quarters* Neg. *** Pos. **** 
Negative control 40 46 86 53.7%   
Positive control  4 17 21 13.1% 75.5%  
Novel germicide. 0 4 4 3.3% 95.3% 80.9% 
 
* 160 eligible quarters per treatment group 
** Number of confirmed clinical mastitis incidences; included in total of new infections. 
*** P < 0.01 Significant reduction in the number of new IMI compared to negative control. 
**** P < 0.01 Significant reduction in the number of new IMI compared to positive control. 
 
 
 
